{"nct_id":"NCT05509023","title":"Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-10","start_date":"2022-09-30","start_date_type":"ACTUAL","primary_completion_date":"2024-12","primary_completion_date_type":"ESTIMATED","completion_date":"2024-12","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["QTTB"]}